Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000;2(5):356-60.
doi: 10.1186/ar112. Epub 2000 Jun 23.

Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis

Affiliations
Review

Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis

C Ritchlin. Arthritis Res. 2000.

Abstract

There is mounting evidence indicating that the synovial fibroblast is a direct effector of tissue injury and matrix remodeling in inflammatory synovitis. Through the elaboration of effector signals including cytokines and chemokines, mesenchymal cells stimulate or suppress inflammation via autocrine and paracrine mechanisms. Synovial fibroblasts are the principal cells mediating joint destruction through secretion of metalloproteinases, and recent evidence suggests that they may also promote bone resorption by stimulating osteoclastogenesis. Moreover, they may play an integral role in the initial phases of synovitis by releasing chemokines that recruit leukocytes to the joint, and cytokines that trigger angiogenesis. Studies focusing on synoviocyte-leukocyte interactions mediated via the cytokine network and the role of cell-cell contact in driving synoviocyte activation will help define the complex interplay that leads to the initiation and perpetuation of synovial inflammation.

PubMed Disclaimer

References

    1. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? . Arthritis Rheum. 1996;39:1781–1790. - PubMed
    1. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? . Arthritis Rheum. 1997;40:5–18. - PubMed
    1. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997;40:598–609. - PubMed
    1. Koopman WJ, Moreland LW. Rheumatoid arthritis: anticytokine therapies on the horizon. Ann Internal Med. 1998;128:231–233. - PubMed
    1. Finck B, Martin R, Fleschmann R, Moreland LW, Schiff M, Barton J. A phase III trial of etanercept vs methotrexate (MTX) in early rheumatoid arthritis (Embrel® ERA Trial) [abstract]. . Arthritis Rheum. 1999;42:s117.